"Designing Growth Strategies is in our DNA"

Asia Pacific Insulin Pump Market Size, Share & COVID-19 Impact Analysis, By Product Type (Pumps [Tethered Pumps, Patch Pumps, and Others] and Consumables), By Disease Indication (Type 1 Diabetes and Type 2 Diabetes), By Distribution Channel (Hospital Pharmacy and Retail & Online Pharmacy), and Regional Forecast, 2023-2030

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI107537

 


To get information on various segments, share your queries with us

  ATTRIBUTE

  DETAILS

Study Period

2019-2030

Base Year

2022

Estimated Year

2023

Forecast Period

2023-2030

Historical Period

2019-2021

Growth Rate

CAGR of 20% from 2023 to 2030

Unit

Value (USD billion)

Segmentation

Type; Diabetes Type; Distribution Channel; and Country/Sub-Region

By Type

  • Pumps
    • Tethered
    • Patch
    • Others
  • Consumables

By Diabetes Type

  • Diabetes 1
  • Diabetes 2

By Distribution Channel

  • Hospital Pharmacies
  • Retail & Online Pharmacies

 

By Country/Sub-Region

  • China (By Diabetes Type)
  • India (By Diabetes Type)
  • Japan (By Diabetes Type)
  • Australia (By Diabetes Type)
  • Southeast Asia (By Diabetes Type)
  • Rest of Asia Pacific (By Diabetes Type)
  • 2019-2030
  • 2022
  • 2019-2021
  • 80
Download Free Sample

    man icon
    Mail icon
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann